| Drug Type Small molecule drug | 
| Synonyms JKB 133, JKB-133, TJC-0133 | 
| Target | 
| Action antagonists | 
| Mechanism TLR4 antagonists(Toll like receptor 4 antagonists) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Hepatitis, Autoimmune | Preclinical | Taiwan Province  | - | |
| Hepatitis, Autoimmune | Preclinical | Taiwan Province  | - | |
| Nonalcoholic Steatohepatitis | Preclinical | Taiwan Province  | - | |
| Nonalcoholic Steatohepatitis | Preclinical | Taiwan Province  | - | 





